0001213900-24-014064.txt : 20240214 0001213900-24-014064.hdr.sgml : 20240214 20240214162330 ACCESSION NUMBER: 0001213900-24-014064 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240213 ITEM INFORMATION: Unregistered Sales of Equity Securities ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240214 DATE AS OF CHANGE: 20240214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INSPIRE VETERINARY PARTNERS, INC. CENTRAL INDEX KEY: 0001939365 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE SERVICES [0700] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 854359258 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41792 FILM NUMBER: 24638829 BUSINESS ADDRESS: STREET 1: 780 LYNNHAVEN PKWY #400 CITY: VIRGINIA BEACH STATE: VA ZIP: 23452 BUSINESS PHONE: (757) 288-3088 MAIL ADDRESS: STREET 1: 780 LYNNHAVEN PKWY #400 CITY: VIRGINIA BEACH STATE: VA ZIP: 23452 8-K 1 ea193789-8k_inspire.htm CURRENT REPORT
false 0001939365 0001939365 2024-02-14 2024-02-14 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

  

Date of Report (Date of earliest event reported): February 14, 2024 (February 13, 2024)

 

INSPIRE VETERINARY PARTNERS, INC.

(Exact name of registrant as specified in its charter)

 

Nevada   001-41792   85-4359258
(State or other jurisdiction
of incorporation)		   (Commission File Number)   (I.R.S. Employer
Identification No.)

 

780 Lynnhaven Parkway, Suite 400

Virginia Beach, VA

   23452
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (757) 734-5464

  

N/A

(Former name or former address, if changed since last report)

  

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Class A Common Stock, par value $0.0001   IVP   Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 3.02 Unregistered Sales of Equity Securities.

 

On February 14, 2024, Inspire Veterinary Partners, Inc. (“Inspire” or the “Company”) issued 1,214,293 shares of Class A common stock of the Company, par value $0.0001 per share (the “Shares”) to Tumim Stone Capital LLC (“Tumim”), pursuant to the previously disclosed common stock purchase agreement (the “Purchase Agreement”), dated November 30, 2023, by and between Inspire and Tumim, as amended by the previously disclosed letter agreement (the “Letter Agreement”), dated January 19, 2024, by and between Inspire and Tumim. In addition, on February 13, 2024, Inspire issued a warrant (the “Warrant”) to purchase up to 1,654,889 shares of Class A common stock of the Company, par value $0.0001 per share (the “Warrant Shares”), to Tumim pursuant to the Purchase Agreement and the Letter Agreement. Inspire issued the Shares and the Warrant in fulfilment of its obligation to issue “Commitment Shares” to Tumim upon its entry into the Purchase Agreement, as such term is defined in the Letter Agreement and pursuant to the terms set forth in the Letter Agreement and the Purchase Agreement.

 

Inspire issued the Shares and the Warrant to Tumim pursuant to a privately negotiated transaction exempt from registration pursuant to Rule 506(b) of Regulation D under the Securities Act of 1933, as amended. Inspire did not receive any proceeds with respect to the issuance of the Commitment Shares or the Warrant and does not expect to receive any material proceeds from Tumim’s exercise, if any, of the Warrant for the purchase of Warrant Shares.

 

The foregoing description of the Purchase Agreement and Letter Agreement are qualified in their entirety by reference to the Purchase Agreement and the Letter Agreement, copies of which are attached hereto as Exhibits 10.1 and 10.2, respectively, and which are incorporated herein by reference. The foregoing description of the Warrant is qualified in its entirety by reference to the Warrant attached as Exhibit 4.1 to this Current Report on Form 8-K and which is incorporated herein by reference.

 

This Current Report on Form 8-K shall not constitute an offer to sell or a solicitation of an offer to buy any shares of Class A common stock of the Company or any other securities of the Company in any state or jurisdiction in which such an offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.

 

Forward-Looking Statements

 

This Current Report on Form 8-K contains forward-looking statements regarding the Company’s current expectations. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Factors that could cause actual results to differ include, but are not limited to, risks and uncertainties related to the satisfaction of customary closing conditions related to the sale and issuance of additional shares of Class A common stock to Tumim pursuant to the Purchase Agreement. These and other risks and uncertainties are described more fully in the sections captioned “Risk Factors” in the Company’s Registration Statements on Form S-1 related to the Company’s public offerings and in the Company’s other filings with the Commission. Forward-looking statements contained in this Current Report on Form 8-K are made as of the date hereof, and the Company undertakes no duty to update such information, except as required under applicable law.

 

Item. 9.01. Financial Statements and Exhibits

 

Exhibit No.   Description
4.1   Warrant, dated February 13, 2024
10.1(a)   Common Stock Purchase Agreement, dated November 30, 2023, between Inspire Veterinary Partners, Inc. and Tumim Stone Capital LLC
10.2(b)   Letter Agreement, dated January 19, 2024, between Inspire Veterinary Partners, Inc. and Tumim Stone Capital LLC
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

(a) Incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed December 6, 2023.
(b) Incorporated by reference to Exhibit 10.15 to the Registration Statement on Form S-1/A filed January 26, 2024.

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: February 14, 2024 INSPIRE VETERINARY PARTNERS, INC.
     
  By: /s/ Kimball Carr
  Name:  Kimball Carr
  Title: Chair, President and Chief Executive Officer

 

 

2

 

 

 EX-4.1 2 ea193789ex4-1_inspire.htm WARRANT, DATED FEBRUARY 13, 2024

Exhibit 4.1

 

NEITHER THE ISSUANCE AND SALE OF THIS WARRANT NOR THE SHARES OF CLASS A COMMON STOCKISSUABLE UPON EXERCISE OF THIS WARRANT HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR QUALIFIED UNDER ANY APPLICABLE STATE OR FOREIGN SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, PLEDGED, HYPOTHECATED, OR OTHERWISE TRANSFERRED OR ASSIGNED UNLESS (I)  A REGISTRATION STATEMENT COVERING SUCH SECURITIES IS EFFECTIVE UNDER THE SECURITIES ACT, OR (II) THE TRANSACTION IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS UNDER THE SECURITIES ACT AND THE QUALIFICATION REQUIREMENTS UNDER APPLICABLE STATE AND FOREIGN LAW AND, IF THE CORPORATION REQUESTS, AN OPINION SATISFACTORY TO THE CORPORATION TO SUCH EFFECT HAS BEEN RENDERED BY COUNSEL

 

WARRANT

 

Inspire Veterinary Partners, Inc.

 

Warrant Certificate No.: 10

 

Issuance Date: February 13, 2024

 

Warrant Shares: 1,654,889

 

Exercise Price: $0.0001 per Warrant Share

 

THIS WARRANT (this “Warrant”) certifies that, for value received, Tumim Stone Capital LLC, a Delaware limited liability company, or its registered assigns (the “Holder”) is entitled, upon the terms and subject to the conditions set forth herein, at any time on or after the date set forth above (the “Issuance Date”) and on or prior to 5:00 p.m., New York City time on February 13, 2029 (the “Termination Date”), , to subscribe for and purchase from Inspire Veterinary Partners, Inc., a Nevada corporation (the “Company”), shares of Class A common stock, par value $0.0001 per share (the “Class A Common Stock”) up to the number of warrant shares set forth above, subject to adjustment as set forth herein (the “Warrant Shares”), at the exercise price set forth above (the “Exercise Price”).

 

This Warrant has been issued pursuant to the terms of that certain Common Stock Purchase Agreement, dated as of November 30, 2023, by and between the Company and the Holder, as such agreement was subsequently amended by that certain letter agreement by and between the Company and the Holder, dated as of January 19, 2024 (as amended, the “Purchase Agreement”).

 

Section 1.  Definitions. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in the Purchase Agreement.

 

-1-

 

 

Section 2.  Exercise.

 

(a) Aggregate Exercise Price. The aggregate exercise price (“Aggregate Exercise Price”) of this Warrant shall be the number of Warrant Shares in respect of which this Warrant is then being exercised pursuant to this Section 2, multiplied by (b) the Exercise Price. The Holder shall pay to the Company the Aggregate Exercise Price to exercise this Warrant pursuant to Section 2(b).

 

(b) Exercise of Warrant. Exercise of this Warrant may be made, in whole or in part, at any time or times on or after the Issuance Date through the Termination Date by delivery to the Company of a notice of exercise in the form of Exhibit A (the “Notice of Exercise”), duly completed and executed by or on behalf of the Holder. This Warrant may be exercised either by means of a “cash exercise” or a “cashless exercise” (as described in Section 2(c)), as specified in the Notice of Exercise. Within two (2) Trading Days following the date of exercise (the “Exercise Date”), the Holder shall deliver the Aggregate Exercise Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer (unless cashless exercise is specified in the Notice of Exercise). No medallion guarantee

 

(or other type of guarantee or notarization) of any Notice of Exercise be required to exercise this Warrant. The Holder shall not be required to physically surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and this Warrant has been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares available hereunder shall reduce the remaining number of Warrant Shares exercisable hereunder in an amount equal to the number of Warrant Shares so exercised. The Company shall record the number of Warrant Shares purchased and the date of such purchases in the Company’s records and books of account.

 

(c) Cashless Exercise. If this Warrant is exercised, in whole or in part, by means of a “cashless exercise,” then the number of Warrant Shares issuable to the Holder upon such cashless exercise shall be reduced by (i) the number of Warrant Shares so exercised multiplied by (ii) the Exercise Price divided by (iii) the one (1) day VWAP of one (1) share of Class A Common Stock on the Exercise Date. Any reduction of the number of Warrant Shares issuable to the Holder upon such cashless exercise shall not increase the remaining number of Warrant Shares exercisable hereunder. If this Warrant is exercised, in whole or in part, by means of a “cashless exercise” by the Holder, the Company in its sole discretion may waive payment of cash due from the Holder in satisfaction of the exercise price for the Warrants Shares so exercised.

 

(d) Mechanics of Exercise.

 

(i) Delivery of Warrant Shares Upon Exercise. Upon any exercise of this Warrant, the Company shall instruct the Transfer Agent to deliver the number of Warrant Shares issuable to the Holder upon such exercise by electronic transfer of such Warrant Shares to the account of the Holder (or its designee) with DTC through its DWAC delivery system, in accordance with the instructions set forth in the related Notice of Exercise; provided, however, that if, on the Exercise Date, the Warrant Shares are not eligible for participation in the DTC book-entry system or the Holder otherwise requests in the related Notice of Exercise that the Warrant Shares be delivered in the form of a physical certificate, then such Warrant Shares shall be transmitted to the Holder (or its designee) by delivery of a physical certificate, registered on the Company’s share register in the name of the Holder (or its designee), delivered to such party at the address(es) specified by the Holder in the related Notice of Exercise. The Warrant Shares shall be delivered to the Holder (or its designee) by the date that is two (2) Trading Days after the Exercise Date, (such date, the “Warrant Share Delivery Date”). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment of the Aggregate Exercise Price (other than in the case of a cashless exercise or waived by the Company, in each case pursuant to Section 2(c)) is received by the Warrant Share Delivery Date. Delivery of New Warrants Upon Exercise. If this Warrant shall have been exercised in part, the Company shall, at the request of the Holder and upon surrender of this Warrant, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects be identical to this Warrant.

 

-2-

 

 

(ii) 

 

(iii) No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise shall be rounded up or down to the nearest whole share.

 

(iv) Charges, Taxes and Expenses. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder (or its designee) as directed by the Holder; provided, however, that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant, when surrendered, for exercise shall be accompanied by an Assignment Form in the form attached hereto as Exhibit B (the “Assignment Form”) duly executed by the Holder, and the Company may require, as a condition to such transfer, the payment of an amount sufficient to reimburse the Company for any transfer tax incidental thereto.

 

(e) Exchange Cap Limitation. If the Company has not obtained stockholder approval for the issuance of shares of Class A Common Stock in an amount in excess of the Exchange Cap in accordance with the applicable rules of the Trading Market or applicable Eligible Market by the Approval Deadline, then the aggregate number of Warrant Shares issuable upon exercise of this Warrant shall be reduced to that number of shares that, as of immediately following the Issuance Date, would cause the aggregate number of shares of Class A Common Stock then beneficially owned (as calculated pursuant to Section 13(d) of the Exchange Act and Rule 13d-3 promulgated thereunder) by the Holder and its Affiliates to equal one (1) share less than the Exchange Cap.

 

Section 3.  Certain Adjustments.

 

(a) Stock Dividends; Stock Splits; Reclassifications. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes a distribution or distributions on shares of its Class A Common Stock or any other equity or equity equivalent securities payable in shares of Class A Common Stock (which, for avoidance of doubt, shall not include any shares of Class A Common Stock issued by the Company upon exercise of this Warrant), (ii) subdivides outstanding shares of Class A Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock split) outstanding shares of Class A Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of Class A Common Stock any shares of capital stock of the Company, then in each case the Warrant Shares available hereunder following any of the events or transactions described in the foregoing clauses (i) through (iv) shall be adjusted so that the number of remaining Warrant Shares, if any, available hereunder following such adjustment is equal to the proportionate number of Warrant Shares that was available hereunder immediately prior to the occurrence of such event or transaction.

 

(b) Fundamental Transaction. If, at any time while this Warrant is outstanding: (i) the Company, directly or indirectly, in one or more related transactions effects any Fundamental Transaction, then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to the Beneficial Ownership Limitation in Section 2(e)), the number of shares of common stock of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration (the “Alternate Consideration”) receivable as a result of such Fundamental Transaction by a holder of the number of shares of Class A Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard to the Beneficial Ownership Limitation in Section 2(e)). The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the “Successor Entity”) to assume in writing all of the obligations of the Company under this Warrant in accordance with the provisions of this Section 3(d) and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity equivalent to the shares of Class A Common Stock receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price equivalent to the Exercise Price hereunder to such shares of capital stock.

 

-3-

 

 

(c) Calculations. For purposes of this Section 3, the number of shares of Class A Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Class A Common Stock (excluding treasury shares, if any) issued and outstanding.

 

Section 4.  Transfer of Warrant.

 

(a) Transferability. Subject to the transfer conditions referred to in the legend endorsed hereon and compliance with applicable state and foreign securities laws, this Warrant and all rights hereunder are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with an Assignment Form duly executed by the Holder and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender, delivery, if the Company requests, of an opinion satisfactory to the Company rendered by counsel to the effect that the transfer is exempt from the registration and prospectus delivery requirements under the Securities Act and the qualification requirements under applicable state and foreign law, and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable, and in the denomination or denominations specified in the Assignment Form, and shall issue to the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers the Assignment Form to the Company assigning this Warrant in full. This Warrant, if properly assigned pursuant to this Section 4(a), may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.

 

(b) New Warrants. This Warrant may be divided or combined with other Warrants upon presentation hereof at the office of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, duly executed by the Holder. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the initial Issuance Date of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.

 

(c) Warrant Register. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the “Warrant Register”), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other purposes, absent actual notice to the contrary.

 

Section 5.  Miscellaneous.

 

(a) No Rights as Stockholder Until Exercise. This Warrant does not entitle the Holder to any voting rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i).

 

(b) Loss, Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of this Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.

 

-4-

 

 

(c) Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall not be day, other than Saturday, Sunday or other day on which commercial banks in New York City are authorized or required by law to remain closed (a “Business Day”), then such action may be taken or such right may be exercised on the next succeeding Business Day.

 

(d) Authorized Shares. The Company covenants that, during the period this Warrant is outstanding, it will reserve from its authorized and unissued Class A Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.

 

(e) Jurisdiction. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance with the applicable provisions of the Purchase Agreement.

 

(f) Waiver. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder or the Company shall operate as a waiver of such right or otherwise prejudice the Holder’s or the Company’s rights, powers or remedies.

 

(g) Notices. Any notice, request or other document required or permitted to be given hereunder shall be delivered in accordance with the applicable provisions of the Purchase Agreement.

 

(h) Limitation of Liability. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase price of any Class A Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the Company.

 

(i) Remedies. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to seek specific performance of its rights under this Warrant.

 

(j) Successors and Assigns. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable by the Holder.

 

(k) Amendment. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.

 

(l) Severability. The provisions of this Warrant are severable and, in the event that any court of competent jurisdiction shall determine that any one or more of the provisions or part of the provisions contained in this Warrant shall, for any reason, be held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect any other provision or part of a provision of this Warrant, and this Warrant shall be reformed and construed as if such invalid or illegal or unenforceable provision, or part of such provision, had never been contained herein, so that such provisions would be valid, legal and enforceable to the maximum extent possible.

 

(m) Headings. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.

 

[Remainder of page intentionally left blank.]

 

-5-

 

 

IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.

 

 

Company:

   
  Inspire Veterinary Partners, Inc.
     
  By:

/s/ Kimball Carr

  Name:  Kimball Carr
  Title: Chair, President and Chief Executive Officer

 

[Signature page to Pre-Funded Class A Common Stock Purchase Warrant]

 

 

 

 

Exhibit A

 

NOTICE OF EXERCISE

 

 

To: Inspire Veterinary Partners, Inc.
  Attention: Kimball Carr and Richard Frank
  Email: kcarr@inspirevet.com and rfrank@inspirevet.com

 

Re:Warrant of Inspire Veterinary Partners, Inc. (the “Company”) issued on February 13, 2024 (the “Warrant”).

 

(1)The undersigned Holder hereby elects to purchase ____________ Warrant Shares pursuant to the terms of the attached Warrant, and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.

 

(2)Payment shall be made (check applicable box):

 

☐by cash payment in accordance with Section 2(b) of the Warrant; or

 

☐by the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in Section 2(c) of the Warrant, to exercise the Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the “cashless exercise” procedure set forth in Section 2(c).

 

(3)Please issue the Warrant Shares in the name of the undersigned Holder or in the name of such other designee as is specified below, by delivery to the DWAC account specified below:

 

☐The undersigned Holder

 

DWAC Account No.: __________________________________________________________

 

☐Other: Name: _____________________________________________________________________

 

Address: ___________________________________________________________________

 

               ___________________________________________________________________

 

DWAC Account No.: _________________________________________________________

 

   
 

Name of Holder

   
 

Signature of authorized signatory of Holder

   
 

Name of authorized signatory of Holder

   
 

Title of authorized signatory of Holder

   

Date

 

A-1

 

 

Exhibit B

 

ASSIGNMENT FORM

 

To: Inspire Veterinary Partners, Inc.
  Attention: Kimball Carr and Richard Frank
  Email: kcarr@inspirevet.com and rfrank@inspirevet.com

 

Re:Warrant of Inspire Veterinary Partners, Inc. (the “Company”) issued on February 13, 2024 (the “Warrant”).

 

Assignor:

 

Date:

 

(1)The undersigned Assignor is the registered holder of the Warrant and hereby assigns and transfers to the assignee named below (the “Assignee”) the Warrant and all of the rights of Assignor under the Warrant evidenced thereby, with respect to the number of Warrant Shares set forth below:

 

  Name:    
  Address:    
       
       
  Attention:    
  Email:    
  Phone:    
  No. of Warrant Shares:    

 

(2)The undersigned Assignee agrees to take and hold the Warrant and any shares of capital stock to be issued upon exercise of the rights thereunder and any shares issuable upon conversion thereof subject to, and to be bound by, the terms and conditions set forth in the Warrant, to the same extent as if Assignee were the original holder thereof

 

Assignor:

   Assignee:
     

Name of Assignor

   Name of Assignee
     
Signature of authorized signatory of Assignor   Signature of authorized signatory of Assignee
     
Name of authorized signatory of Assignor   Name of authorized signatory of Assignee
     
Title of authorized signatory of Assignor   Title of authorized signatory of Assignee

 

 

B-1

 

 

 

 EX-101.SCH 3 ivp-20240214.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 ivp-20240214_lab.xml XBRL LABEL FILE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 ivp-20240214_pre.xml XBRL PRESENTATION FILE XML 6 R1.htm IDEA: XBRL DOCUMENT v3.24.0.1
Cover
Feb. 14, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Feb. 13, 2024
Entity File Number 001-41792
Entity Registrant Name INSPIRE VETERINARY PARTNERS, INC.
Entity Central Index Key 0001939365
Entity Tax Identification Number 85-4359258
Entity Incorporation, State or Country Code NV
Entity Address, Address Line One 780 Lynnhaven Parkway, Suite 400
Entity Address, City or Town Virginia Beach
Entity Address, State or Province VA
Entity Address, Postal Zip Code 23452
City Area Code 757
Local Phone Number 734-5464
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Class A Common Stock, par value $0.0001
Trading Symbol IVP
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.0.1 html 1 23 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://inspirevet.com/role/Cover Cover Cover 1 false false All Reports Book All Reports ea193789-8k_inspire.htm ivp-20240214.xsd ivp-20240214_lab.xml ivp-20240214_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "ea193789-8k_inspire.htm": { "nsprefix": "IVP", "nsuri": "http://inspirevet.com/20240214", "dts": { "inline": { "local": [ "ea193789-8k_inspire.htm" ] }, "schema": { "local": [ "ivp-20240214.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "ivp-20240214_lab.xml" ] }, "presentationLink": { "local": [ "ivp-20240214_pre.xml" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://inspirevet.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2024-02-14", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "ea193789-8k_inspire.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-02-14", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "ea193789-8k_inspire.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://inspirevet.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 15 0001213900-24-014064-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-24-014064-xbrl.zip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ea193789-8k_inspire_htm.xml IDEA: XBRL DOCUMENT 0001939365 2024-02-14 2024-02-14 iso4217:USD shares iso4217:USD shares false 0001939365 8-K 2024-02-13 INSPIRE VETERINARY PARTNERS, INC. NV 001-41792 85-4359258 780 Lynnhaven Parkway, Suite 400 Virginia Beach VA 23452 757 734-5464 false false false false Class A Common Stock, par value $0.0001 IVP NASDAQ true false